Bullish Case: Helium's IV sits below market at every maturity (41% vs 51% Nov; 50% vs 58% Jun), implying calmer realized path ahead. Term structure is in contango, call volume exceeds puts by 13%, both Helium and market density peak near $35–40 with fat upside tails to $45–50, and the AI forecast of -2.37% has a -0.4 historical correlation, which historically argues contrarian upside. A $36.23 base rebounding off the $35 pivot supports a grind toward $40–45 into 2027 expiries.

Bearish Case: PEGA is down 45% year-over-year, mean-reverting, and 15.3x book with a bearish analyst framing. The market term structure shows elevated June 2027 IV (58%), put skew remains steep (35P IV 59–60%), and deep put wings (90–135% IV) signal persistent downside distrust. A failed $35 hold would reopen the $30–33 zone given the -48.6% two-year drawdown trend.

Potential Outcomes:

• 40%: $33–$37 range holds into Nov 21 expiry; ATM IV ~41 compresses post-event. Falsified by a close below $33.
• 25%: Rebound to $38–$42 by Jan 16, 2027; call IV holds ~42–47 and 40C volume stays dominant.
• 20%: Slide to $30–$33 on demand/ARR concerns; 30P IV rises above 60%.
• 10%: Breakout to $43–$48; Jun 2027 call IV (53–55%) validates upside tails.
• 5%: Shock below $28; deep put IV (>100%) spikes.

Watch Nov 21 and Dec 19 expiries and Q4 earnings (early Feb 2027).

October 22, 2026